{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:46:27Z","timestamp":1774647987119,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.path.2019.08.009","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T07:23:31Z","timestamp":1569655411000},"page":"951-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["A Guide to Pheochromocytomas and Paragangliomas"],"prefix":"10.1016","volume":"12","author":[{"given":"Julie","family":"Guilmette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib1","first-page":"187","article-title":"The incidence rate of phaeochromocytoma and Conn\u2019s syndrome in Denmark, 1977-1981","volume":"2","author":"Andersen","year":"1988","journal-title":"J\u00a0Hum Hypertens"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1365-2796.1994.tb00861.x","article-title":"Incidence of pheochromocytoma in South Galicia, Spain","volume":"236","author":"Fernandez-Calvet","year":"1994","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.4103\/2230-8210.137514","article-title":"A\u00a0retrospective study of surgically excised phaeochromocytomas in Newfoundland, Canada","volume":"18","author":"Holland","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.009_bib4","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ajcp\/49.3.387","article-title":"Hyaline globules of the adrenal medulla","volume":"49","author":"Hart","year":"1968","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib6","first-page":"353","article-title":"Hyaline globules of the adrenal medulla of man. A product of lipid peroxidation?","volume":"91","author":"Dekker","year":"1971","journal-title":"Arch Pathol"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib7","first-page":"155","article-title":"The diffuse endocrine system: from embryogenesis to carcinogenesis","volume":"38","author":"Montuenga","year":"2005","journal-title":"Prog Histochem Cytochem"},{"key":"10.1016\/j.path.2019.08.009_bib8","series-title":"WHO classification of the tumours of endocrine organs","first-page":"181","article-title":"Phaeochromocytoma","author":"Tischler","year":"2017"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP14481.RA","article-title":"Pheochromocytoma and paraganglioma","volume":"21","author":"Pacak","year":"2015","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib11","first-page":"76","article-title":"Biochemical diagnosis of pheochromocytoma","volume":"31","author":"Eisenhofer","year":"2004","journal-title":"Front Horm Res"},{"issue":"9486","key":"10.1016\/j.path.2019.08.009_bib12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaechromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.path.2019.08.009_bib13","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment a scientific statement from the american heart association professional education committee of the council for high blood pressure research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.regpep.2010.06.003","article-title":"Granins and their derived peptides in normal and tumoral chromaffin tissue: implications for the diagnosis and prognosis of pheochromocytoma","volume":"165","author":"Gu\u00e9rin","year":"2010","journal-title":"Regul Pept"},{"issue":"5","key":"10.1016\/j.path.2019.08.009_bib15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1530\/eje.0.1500681","article-title":"Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients","volume":"150","author":"Baguet","year":"2004","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.path.2019.08.009_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.4065\/70.8.757","article-title":"Spells: in search of a cause","volume":"70","author":"Young","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"7","key":"10.1016\/j.path.2019.08.009_bib17","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ejim.2009.08.002","article-title":"ACTH-producing pheochromocytoma: clinical considerations and concise review of the literature","volume":"20","author":"Nijhoff","year":"2009","journal-title":"Eur J Intern Med"},{"issue":"8","key":"10.1016\/j.path.2019.08.009_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-2006-924154","article-title":"Cushing\u2019s syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction","volume":"114","author":"Bayraktar","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"596","key":"10.1016\/j.path.2019.08.009_bib19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/pgmj.51.596.416","article-title":"Watery diarrhoea and hypokalaemia associated with a phaeochromocytoma","volume":"51","author":"Loehry","year":"1975","journal-title":"Postgrad Med J"},{"issue":"13","key":"10.1016\/j.path.2019.08.009_bib20","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","author":"Pacak","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","author":"Yang","year":"2015","journal-title":"J\u00a0Mol Med"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib22","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1210\/jcem.86.11.8034","article-title":"Benign paragangliomas: Clinical presentation and treatment outcomes in 236 patients","volume":"86","author":"Erickson","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib23","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1530\/ERC-11-0369","article-title":"Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients","volume":"19","author":"Piccini","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.path.2019.08.009_bib25","doi-asserted-by":"crossref","first-page":"T123","DOI":"10.1530\/ERC-15-0261","article-title":"Pathology of pheochromocytoma and paraganglioma","volume":"22","author":"Tischler","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/1097-0142(197707)40:1<275::AID-CNCR2820400140>3.0.CO;2-D","article-title":"Pheochromocytoma with angiomatous features. A case report and ultrastructural study","volume":"40","author":"Shin","year":"1977","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib27","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/BF02739777","article-title":"Composite pheochromocytoma-ganglioneuroma of the adrenal gland: An uncommon entity with distinctive clinicopathologic features","volume":"10","author":"Lam","year":"1999","journal-title":"Endocr Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib28","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0046-8177(90)90155-X","article-title":"Histopathology of benign versus malignant sympathoadrenal paragangliomas: Clinicopathologic study of 120 cases including unusual histologic features","volume":"21","author":"Ilona Linnoila","year":"1990","journal-title":"Hum Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0377-4929.130924","article-title":"Malignant peripheral nerve sheath tumor of adrenal gland with heterologus osseous differentiation in a case of von Recklinghausen\u2019s disease","volume":"57","author":"Baisakh","year":"2014","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.asjsur.2012.11.003","article-title":"Composite pheochromocytoma with a malignant peripheral nerve sheath tumor: case report and review of the literature","volume":"39","author":"Namekawa","year":"2016","journal-title":"Asian J Surg"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib31","first-page":"115","article-title":"Composite pheochromocytoma-ganglioneuroma: a rare experiment of nature","volume":"5","author":"Khan","year":"2009","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/jcp.51.6.477","article-title":"Cytokeratin expression in adrenal phaeochromocytomas and extra-adrenal paragangliomas","volume":"51","author":"Chetty","year":"1998","journal-title":"J\u00a0Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib33","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/00000478-200111000-00010","article-title":"Increased expression of tenascin in pheochromocytomas correlates with malignancy","volume":"25","author":"Salmenkivi","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/EP:16:1:023","article-title":"Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: a clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors","volume":"16","author":"Kimura","year":"2005","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.path.2019.08.009_bib36","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2019.08.009_bib37","first-page":"E242","article-title":"Risk stratification on pheochromocytoma and paraganglioma from laboratory and clinical medicine","volume":"7","author":"Kimura","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.surg.2008.02.007","article-title":"Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle\/apoptosis gene expression analysis","volume":"143","author":"Strong","year":"2008","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.path.2019.08.009_bib39","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00268-010-0744-5","article-title":"Size of the tumor and pheochromocytoma of the adrenal gland scaled score (PASS): Can they predict malignancy?","volume":"34","author":"Agarwal","year":"2010","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib40","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.urology.2006.02.019","article-title":"Development and validation of pheochromocytoma of the adrenal gland scaled score for predicting malignant pheochromocytomas","volume":"68","author":"Gao","year":"2006","journal-title":"Urology"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib41","doi-asserted-by":"crossref","first-page":"e0187398","DOI":"10.1371\/journal.pone.0187398","article-title":"Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma","volume":"12","author":"Koh","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib42","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.3390\/cancers11020225","article-title":"The value of histological algorithms to predict the malignancy potential of pheochromocytomas and abdominal paragangliomas\u2014A meta-analysis and systematic review of the literature","volume":"11","author":"Stenman","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"19","key":"10.1016\/j.path.2019.08.009_bib43","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1056\/NEJMoa020152","article-title":"Germ-line mutations in nonsyndromic pheochromocytoma","volume":"346","author":"Neumann","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"34","key":"10.1016\/j.path.2019.08.009_bib44","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","author":"Amar","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.currproblcancer.2014.01.001","article-title":"Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment","volume":"38","author":"Martucci","year":"2014","journal-title":"Curr Probl Cancer"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/er.2017-00062","article-title":"New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification","volume":"38","author":"Crona","year":"2017","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib49","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","article-title":"Genomic landscape of pheochromocytoma and paraganglioma","volume":"4","author":"Jochmanova","year":"2018","journal-title":"Trends Cancer"},{"issue":"53","key":"10.1016\/j.path.2019.08.009_bib50","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1038\/sj.onc.1204991","article-title":"Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma","volume":"20","author":"Koch","year":"2001","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.path.2019.08.009_bib51","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0031-1301302","article-title":"An update on the genetics of paraganglioma, pheochromocytoma, and associated hereditary syndromes","volume":"44","author":"Gimenez-Roqueplo","year":"2012","journal-title":"Horm Metab Res"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib52","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","author":"Haissaguerre","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib53","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1530\/EC-13-0009","article-title":"Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma","volume":"2","author":"Crona","year":"2016","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10689-012-9584-9","article-title":"10 rare tumors that warrant a genetics referral","volume":"12","author":"Banks","year":"2013","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib55","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","author":"Astuti","year":"2002","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib56","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-2007-970407","article-title":"Genetics and biology of pheochromocytoma","volume":"115","author":"Mannelli","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","author":"Niemann","year":"2000","journal-title":"Nat Genet"},{"issue":"5454","key":"10.1016\/j.path.2019.08.009_bib58","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","author":"Baysal","year":"2000","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.path.2019.08.009_bib59","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.medcli.2018.02.019","article-title":"Hereditary paraganglioma-pheochromocytoma syndrome","volume":"151","author":"Sanchez Cifuentes","year":"2018","journal-title":"Med Clin (Barc)"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s003450050102","article-title":"Pheochromocytoma: evaluation, diagnosis, and treatment","volume":"17","author":"Walther","year":"2002","journal-title":"World J Urol"},{"issue":"9","key":"10.1016\/j.path.2019.08.009_bib61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib62","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/his.13373","article-title":"Hereditary and familial thyroid tumours","volume":"72","author":"Guilmette","year":"2018","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib63","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2796.1995.tb01211.x","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2: European study","volume":"238","author":"Modigliani","year":"1995","journal-title":"J\u00a0Intern Med"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib64","doi-asserted-by":"crossref","first-page":"176","DOI":"10.4158\/EP13268.RA","article-title":"Genetics, diagnosis, and management of medullary thyroid carcinoma and pheochromocytoma\/paraganglioma","volume":"20","author":"Moraitis","year":"2014","journal-title":"Endocr Pract"},{"issue":"1\u20132","key":"10.1016\/j.path.2019.08.009_bib65","first-page":"92","article-title":"Familial pheochromocytomas and paragangliomas","volume":"386","author":"King","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib66","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.semcancer.2012.05.005","article-title":"Von Hippel-Lindau: how a rare disease illuminates cancer biology","volume":"23","author":"Richard","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"9374","key":"10.1016\/j.path.2019.08.009_bib67","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(03)13643-4","article-title":"von Hippel-Lindau disease","volume":"361","author":"Lonser","year":"2003","journal-title":"Lancet"},{"issue":"3Pt 1","key":"10.1016\/j.path.2019.08.009_bib68","first-page":"659","article-title":"Clinical and genetic characterization of pheochromocytoma in von Hippel- Lindau families: Comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma","volume":"162","author":"Walther","year":"1999","journal-title":"J\u00a0Urol"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib69","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/ejhg.2010.175","article-title":"von Hippel-Lindau disease: a clinical and scientific review","volume":"19","author":"Maher","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib70","first-page":"123","article-title":"Von Hippel-Lindau disease","volume":"1085","author":"Tsang","year":"2018","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib71","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000345668","article-title":"Von Hippel-Lindau syndrome","volume":"41","author":"Chou","year":"2013","journal-title":"Front Horm Res"},{"issue":"5","key":"10.1016\/j.path.2019.08.009_bib72","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","author":"Eisenhofer","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"21","key":"10.1016\/j.path.2019.08.009_bib73","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1056\/NEJM199311183292103","article-title":"Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau Disease","volume":"329","author":"Neumann","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.path.2019.08.009_bib74","first-page":"4101","article-title":"Sporadic pheochromocytomas are rarely associated with germline mutations in the vhl tumor suppressor gene or the ret protooncogene","volume":"82","author":"Brauch","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib75","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(19980729)77:3<337::AID-IJC5>3.0.CO;2-P","article-title":"Germline mutations in the vhl gene in patients presenting with phaeochromocytomas","volume":"77","author":"Van der Harst","year":"1998","journal-title":"Int J Cancer"},{"issue":"suppl 11","key":"10.1016\/j.path.2019.08.009_bib76","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1002\/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.0.CO;2-5","article-title":"Von Hippel-Lindau syndrome. A pleomorphic condition","volume":"86","author":"Friedrich","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib77","first-page":"20","article-title":"A\u00a0review of Von Hippel-Lindau syndrome","volume":"4","author":"Varshney","year":"2017","journal-title":"J\u00a0Kidney Cancer VHL"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib78","doi-asserted-by":"crossref","first-page":"R253","DOI":"10.1530\/ERC-11-0170","article-title":"Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas","volume":"18","author":"Welander","year":"2011","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib79","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ccr.2007.12.027","article-title":"Plexiform and dermal neurofibromas and pigmentation are caused by NF1 loss in desert hedgehog-expressing cells","volume":"13","author":"Wu","year":"2008","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.path.2019.08.009_bib80","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2006-0780","article-title":"Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma","volume":"91","author":"Bausch","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib81","first-page":"417","article-title":"Risk-oriented approach to hereditary adrenal pheochromocytoma","volume":"1073","author":"Machens","year":"2006","journal-title":"Front Horm Res"},{"issue":"11","key":"10.1016\/j.path.2019.08.009_bib82","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jmg.26.11.712","article-title":"A\u00a0genetic study of von Recklinghausen neurofibromatosis in south east Wales. II Guidelines for genetic counselling","volume":"26","author":"Huson","year":"1989","journal-title":"J\u00a0Med Genet"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/cen.12218","article-title":"Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma\/paraganglioma patients with clinical characteristics of hereditary syndromes","volume":"79","author":"Peczkowska","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib84","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/modpathol.3880513","article-title":"Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen\u2019s disease","volume":"15","author":"Kimura","year":"2002","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.path.2019.08.009_bib85","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2796.2009.02111.x","article-title":"SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes","volume":"266","author":"Pasini","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib86","doi-asserted-by":"crossref","first-page":"T91","DOI":"10.1530\/ERC-15-0268","article-title":"Clinical manifestations of paraganglioma syndromes types 1-5","volume":"22","author":"Benn","year":"2015","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.path.2019.08.009_bib87","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.seminoncol.2010.10.017","article-title":"Metastatic paraganglioma","volume":"37","author":"Fliedner","year":"2010","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.path.2019.08.009_bib88","doi-asserted-by":"crossref","first-page":"L13","DOI":"10.1530\/ERC-13-0530","article-title":"Clinicopathological study of SDHB mutation-related pheochromocytoma and sympathetic paraganglioma","volume":"21","author":"Kimura","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"4","key":"10.1016\/j.path.2019.08.009_bib89","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1677\/ERC-09-0316","article-title":"SDHB loss predicts malignancy in pheochromocytomas\/sympathethic paragangliomas, but not through hypoxia signalling","volume":"17","author":"Blank","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.path.2019.08.009_bib90","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/ncpendmet0396","article-title":"Pheochromocytoma: recommendations for clinical practice from the first international symposium","volume":"3","author":"Pacak","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918119300650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:41:18Z","timestamp":1761748878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918119300650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":90,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1875918119300650"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2019.08.009","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Guide to Pheochromocytomas and Paragangliomas","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2019.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}